BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38250037)

  • 1. Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses.
    Zhang C; Nan X; Zhang B; Wu H; Zeng X; Song Z; Li S; Wang J; Xie S; Zhang G; Xiu H; Wang J; Guo J; Wang P; Cai Z; Zhen Y; Shen Y
    Theranostics; 2024; 14(3):1010-1028. PubMed ID: 38250037
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
    Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
    J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
    Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
    J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between CD93, C1q and GIPC in the Regulation of Pneumococcal Meningitis Inflammation.
    Qiao N; Zhang J; Zhang Y; Liu X
    Ann Clin Lab Sci; 2022 Jul; 52(4):634-641. PubMed ID: 36197773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoimaging of
    Liu W; Zhang C; Cao H; Shi D; Zhao S; Liang T; Hou G
    Oncol Lett; 2019 Dec; 18(6):6413-6422. PubMed ID: 31819775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
    Greenlee-Wacker MC; Briseño C; Galvan M; Moriel G; Velázquez P; Bohlson SS
    J Immunol; 2011 Sep; 187(6):3353-61. PubMed ID: 21849679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q.
    McGreal EP; Ikewaki N; Akatsu H; Morgan BP; Gasque P
    J Immunol; 2002 May; 168(10):5222-32. PubMed ID: 11994479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
    Lee CH; Bae JH; Choe EJ; Park JM; Park SS; Cho HJ; Song BJ; Baek MC
    Theranostics; 2022; 12(5):1971-1987. PubMed ID: 35265193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 10. The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
    Lee JW; Zhang Y; Eoh KJ; Sharma R; Sanmamed MF; Wu J; Choi J; Park HS; Iwasaki A; Kaftan E; Chen L; Papadimitrakopoulou V; Herbst RS; Koo JS
    J Thorac Oncol; 2019 Jun; 14(6):1046-1060. PubMed ID: 30771521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.
    Kao YC; Jiang SJ; Pan WA; Wang KC; Chen PK; Wei HJ; Chen WS; Chang BI; Shi GY; Wu HL
    PLoS One; 2012; 7(12):e51647. PubMed ID: 23272129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
    Ikewaki N; Yamao H; Kulski JK; Inoko H
    J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
    Watabe S; Kikuchi Y; Morita S; Komura D; Numakura S; Kumagai-Togashi A; Watanabe M; Matsutani N; Kawamura M; Yasuda M; Uozaki H
    Cancer Med; 2020 Apr; 9(8):2879-2890. PubMed ID: 32091667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
    Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
    J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.
    Akbay EA; Koyama S; Liu Y; Dries R; Bufe LE; Silkes M; Alam MM; Magee DM; Jones R; Jinushi M; Kulkarni M; Carretero J; Wang X; Warner-Hatten T; Cavanaugh JD; Osa A; Kumanogoh A; Freeman GJ; Awad MM; Christiani DC; Bueno R; Hammerman PS; Dranoff G; Wong KK
    J Thorac Oncol; 2017 Aug; 12(8):1268-1279. PubMed ID: 28483607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
    Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
    Front Immunol; 2018; 9():2538. PubMed ID: 30473695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.
    Bose RJC; Uday Kumar S; Zeng Y; Afjei R; Robinson E; Lau K; Bermudez A; Habte F; Pitteri SJ; Sinclair R; Willmann JK; Massoud TF; Gambhir SS; Paulmurugan R
    ACS Nano; 2018 Nov; 12(11):10817-10832. PubMed ID: 30346694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
    Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.